Predictors of Spontaneous and Systematically Assessed Suicidal Adverse Events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) Study
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The authors sought to identify predictors of self-harm adverse events in treatment-resistant, depressed adolescents during the first 12 weeks of treatment. METHOD: Depressed adolescents (N=334) who had not responded to a previous trial with an SSRI antidepressant were randomized to a switch to either another SSRI or venlafaxine, with or without cognitive behavior therapy. Self-harm events, i.e., suicidal and non-suicidal self-injury adverse events were assessed by spontaneous report for the first 181 participants, and by systematic weekly assessment for the last 153 participants. RESULTS: Higher rates of suicidal (20.8% vs. 8.8%) and nonsuicidal self-injury (17.6% vs. 2.2%), but not serious adverse events (8.4% vs. 7.3%) were detected with systematic monitoring. Median time to a suicidal event was 3 weeks, predicted by high baseline suicidal ideation, family conflict, and drug and alcohol use. Median time to nonsuicidal self-injury was 2 weeks, predicted by previous history of nonsuicidal self-injury. While there were no main effects of treatment, venlafaxine treatment was associated with a higher rate of self-harm adverse events in those with higher suicidal ideation. Adjunctive use of benzodiazepines, while in a small number of participants (N=10) was associated with higher rate of both suicidal and nonsuicidal self-injury adverse events. CONCLUSIONS: Since predictors of suicidal adverse events also predict poor response to treatment, and many of these events occurred early in treatment, improving the speed of response to depression, by targeting of family conflict, suicidal ideation, and drug use may help to reduce their incidence. The relationship of venlafaxine and of benzodiazepines to self-harm events requires further study and clinical caution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More promisingly, antidepressants reduced suicidal ideation in 9/12 studies that reported effects on suicidal ideation.(55, 57, 59–65)”
From Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review (2021) · cites this paper as [65]
In the citing paper
“Three adolescent and young adult RCT studies found antidepressants reduced suicidal ideation,(62, 64, 65) one did not,(85) and none found a reduction in suicide behavior.”
From Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review (2021) · cites this paper as [65]
Citations
Cites
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696 · cited 2×
“Subjects were assigned to treatment using a variation of Efron’s biased coin toss (15), balancing both across and within sites with respect to incoming treatment medication, comorbid anxiety, chronic depression (duration ≥24 months), and BDI item 9 (suicidal ideation) ≥2.”
MethodKAUFMAN, J., BIRMAHER, B., BRENT, D., RAO, U., FLYNN, C., MORECI, P., WILLIAMSON, D., & RYAN, N. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199707000-00021 · Cited by 10,148 · cited 1×
“Diagnostic information was obtained by the School Age Schedule for Affective Disorders and Schizophrenia for School-Aged Children-Present and Lifetime Version (K-SADS-PL) ( 16 ) at baseline.”
MethodSelf-citationThe measurement of pessimism: the hopelessness scale
Beck, A. T., Weissman, A., Lester, D., & Trexler, L. (1974) · Journal of Consulting and Clinical Psychology · doi:10.1037/h0037562 · Cited by 5,494 · cited 1×
“Self-rated depression, hopelessness, and suicidal ideation were assessed using the Beck Depression Inventory (BDI) (18), Beck Hopelessness Scale (19), and Suicide Ideation Questionnaire—JR (20), respectively.”
MethodA Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
Non-suicidal self-injury among adolescents: Diagnostic correlates and relation to suicide attempts
NOCK, M., JOINERJR, T., GORDON, K., LLOYDRICHARDSON, E., & PRINSTEIN, M. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2006.05.010 · Cited by 1,617 · cited 1×
“Although the clinical characteristics of those with suicidal and nonsuicidal adverse events overlap ( 27 ), the clinical implications of suicidal adverse events were more serious, insofar as the occurrence of suicidal, but not nonsuicidal self-injury, adverse events was associated with a poorer response to treatment.”
BackgroundA Functional Approach to the Assessment of Self-Mutilative Behavior.
Nock, M. K., & Prinstein, M. J. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.5.885 · Cited by 1,536 · cited 1×
“A “serious suicidal or nonsuicidal self-injury adverse event” was an event that led to hospitalization, was life-threatening, disabling, or resulted in death ( 25 ).”
BackgroundBridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086 · cited 3×
“During the first half of the study, participants were monitored for self-harm adverse events by spontaneous report, similar to previous studies (1, 10).”
BackgroundResultSelf-citationSuicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054 · cited 3×
“During the first half of the study, participants were monitored for self-harm adverse events by spontaneous report, similar to previous studies (1, 10).”
ResultPosner, K., Oquendo, M. A., Gould, M., Stanley, B., & Davies, M. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1035 · Cited by 1,025 · cited 4×
“This scale consists of two items: 1) a rating of suicidal ideation ranging from 0 to 5 (no ideation to suicidal ideation with intent and a clear plan) and 2) a rating of suicidal behavior, ranging from 0 to 5 (no behavior to multiple attempts during the assessment period) using the Columbia Classification Algorithm of…”
BackgroundMethodInfluential(2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1132 · Cited by 752
Self-citation
Research works printed but not linked: 9
- Apter A, 2006, J Child Adolesc Psychopharmacology, 16
- Hammad T, 2004, US Food and Drug Administration., 19
- Brent DA, JAMA 2008: 901-913
- US Food and Drug Administration, 2003, FDA Talk Paper.
- American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Health-IV
- Poznanski EO, 1984, Depression Rating Scale-Revised. Psychopharmacol Bull, 21, 979
- Guy W, 1976, Clinical Global Improvement Scale: Assessment Manual of Psychopharmacology 76
- Robin AL, 1995, Dictionary of Behavorial Techniques, 148
- Asarnow J, Keller MB
Cited by
Items 101–200 of 237
Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents
Gibbons, R. D., Coca Perraillon, M., Hur, K., Conti, R. M., Valuck, R. J., & Brent, D. A. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3713 · Cited by 24
Self-citationIs Adolescent Suicidal Ideation Continuous or Categorical? A Taxometric Analysis
Liu, R. T., Jones, R. N., & Spirito, A. (2015) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-015-0022-y · Cited by 25
Self-citationStrawn, J. R., Aaronson, S. T., Elmaadawi, A. Z., Schrodt, G. R., Holbert, R. C., Verdoliva, S., Heart, K. L., Demitrack, M. A., & Croarkin, P. E. (2020) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2020.0008 · Cited by 24
Selecting Suicide Ideation Assessment Instruments: A Meta-Analytic Review
Erford, B. T., Jackson, J., Bardhoshi, G., Duncan, K., & Atalay, Z. (2018) · Measurement and Evaluation in Counseling and Development · doi:10.1080/07481756.2017.1358062 · Cited by 22
“Brent et al. (2009) reported test–retest reliability separately for the suicidal ideation items (rtt = .90 [.79, 1.00], n = 334) and suicidal behavior items (rtt = 1.00 [.89, 1.00], n = 334), coefficients that are very respectable, and higher than α. Posner et al. (2011) reported significant…”
MethodInfluentialSuicide Prevention Interventions and Referral/Follow-Up Services: A Systematic Review
O'Neil, M. E., Peterson, K., Low, A., Carson, S., Denneson, L. M., Haney, E. M., Shiroma, P. R., & Kansagara, D. L. (2012) · Cited by 26
Cox, L. J., Stanley, B., Melhem, N., Oquendo, M. A., Birmaher, B. B., Burke, A. K., Kolko, D. J., Zelazny, J. M., Mann, J. J., Porta, G., et al. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07196 · Cited by 22
Self-citationChoe, C. J., Emslie, G. J., & Mayes, T. L. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.002 · Cited by 26
Self-citationChen, X., Dong, Y., Ye, M., Wang, X., Yan, J., Yao, Y., Zhou, Q., Qian, C., & Liu, Z. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06735-1 · Cited by 22
Hetrick, S. E., Thompson, A., Yuen, K., Finch, S., & Parker, A. G. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-178 · Cited by 21
“Together with research that has highlighted that a reliance on spontaneous report of side effects does not sufficiently identify all those at risk of suicide [20], the current results provide further impetus for services to invest in systems that allow regular collection of standardized information about adverse effec…”
A Review of Methods for Monitoring Adverse Events in Pediatric Psychopharmacology Clinical Trials
Coates, M., Spanos, M., Parmar, P., Chandrasekhar, T., & Sikich, L. (2018) · Drug Safety · doi:10.1007/s40264-017-0633-z · Cited by 23
“underestimate AEs compared with a more systematic approach [9].”
BackgroundSørensen, J. Ø., Rasmussen, A., Roesbjerg, T., Verhulst, F. C., & Pagsberg, A. K. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13360 · Cited by 21
Liu, H., Wen, Y., Liang, X., Xu, Y., Qiao, D., Yang, C., Han, M., Li, H., Ren, T., Zhang, X., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.972870 · Cited by 21
“The results of a study in the group of adolescent refractory depression show that the subjects who choose SSRI for intervention have the lowest incidence of self-injury behavior (Brent et al., 2009).”
Asking about Suicide as Suicide Prevention: The Columbia Suicide Severity Rating Scale (C-SSRS)
Yershova, K. V., Lesser, A., Logan, K., & Posner, K. (2016) · Springer eBooks · doi:10.1007/978-3-319-26282-6_3 · Cited by 24
“(2011) Brent et al. (2009)”
Gyllenberg, D., & Sourander, A. (2012) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.644809 · Cited by 21
Predictors of suicide in adolescents and adults with mood and common comorbid disorders
Barzilay, S., & Apter, A. S. (2014) · Neuropsychiatry · doi:10.2217/npy.13.86 · Cited by 22
Parker, B., Achilles, M. R., Subotic-Kerry, M., & O’Dea, B. (2020) · BMC Family Practice · doi:10.1186/s12875-019-1071-z · Cited by 18
Hilton, R., Rengasamy, M. L., Mansoor, B., He, J., Mayes, T. L., Emslie, G. J., Porta, G., Clarke, G. N., Wagner, K. D., Birmaher, B. B., et al. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.02.013 · Cited by 22
Self-citationGentile, S. (2010) · Reviews on Recent Clinical Trials · doi:10.2174/157488710790820517 · Cited by 17
Raising the bar for youth suicide prevention
Robinson, J. (2016) · Cited by 24
Aswar, U. M., Shende, H., & Aswar, M. K. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000679 · Cited by 14
Wagner, K. D., Asarnow, J. R., Vitiello, B., Clarke, G., Keller, M. B., Emslie, G. J., Ryan, N. D., Porta, G., Iyengar, S., Ritz, L., et al. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0045 · Cited by 14
“During this trial, we were able to establish reliablility of the measure (Brent et al. 2009).”
InfluentialSelf-citationAttachment-based family therapy with a 13-year-old girl presenting with high risk for suicide
Krauthamer Ewing, E. S., Levy, S. A., Boamah‐Wiafe, L., Kobak, R., & Diamond, G. (2016) · Journal of Marital and Family Therapy · doi:10.1111/jmft.12102 · Cited by 13
“High family conflict, low cohesion, and ineffective parenting are strong risk factors for youth suicide and depression, and family conflict is frequently a negative moderator of treatment outcome (Asarnow et al., 2009; Birmaher et al., 2000; Brent et al., 2009; Feeny et al., 2009).”
BackgroundTeenaged, Depressed, and Treatment Resistant: What Predicts Self-Harm?
Weissman, M. M. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020265 · Cited by 13
“In the report featured in this issue (7), the authors attempt to identify the predictors of self-harm adverse events during the course of the trial.”
The treatment of SSRI‐Resistant Depression in Adolescents (TORDIA): in search of the best next step
Brent, D. A. (2009) · Depression and Anxiety · doi:10.1002/da.20617 · Cited by 12
“Suicidal events may be prevented by early interventions to promote reduction in drug and alcohol abuse, family conflict, and increase commitment to treatment and to a safety plan.([5]) Depressed patients with sleep difficulties represent a group at high-risk for nonresponse, and, ideally, should first be managed with…”
BackgroundSelf-citationFrom TADS and SOFTADS to TORDIA and Beyond: What’s New in the Treatment of Adolescent Depression?
Yu, Z. J., Kratochvil, C. J., Weller, R. A., Mooreville, M., & Weller, E. B. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0094-x · Cited by 16
“Furthermore, adjunctive use of benzodiazepines also increased the rate of suicidal and nonsuicidal selfinjury [34].”
BackgroundPost-marketing Drug Safety Evaluation Using Data Mining Based on FAERS
Duan, R., Zhang, X., Du, J., Huang, J. Y., Tao, C., & Chen, Y. (2017) · Lecture notes in computer science · doi:10.1007/978-3-319-61845-6_38 · Cited by 11
Nicht-suizidale Selbstverletzung (NSSV) und Suizidalität in der Adoleszenz
Plener, P. L., Fegert, J. M., & Freyberger, H. J. (2011) · Zeitschrift für Psychiatrie Psychologie und Psychotherapie · doi:10.1024/1661-4747/a000095 · Cited by 14
Identifying the best treatment for young people with depression
Strawn, J. R., & Walkup, J. T. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30236-4 · Cited by 12
Suizidalität im Kindes- und Jugendalter
Groschwitz, R. C., Kapusta, N. D., & Plener, P. L. (2017) · Nervenheilkunde · doi:10.1055/s-0038-1627009 · Cited by 11
“So konnte gezeigt werden, dass Jugendliche und junge Erwachsene ein erhöhtes Risiko für das Auftreten von suizidalem Verhalten und selbstschädigendem Verhalten nach SSRI Verschreibungen aufweisen (48, 51), das vor allem bei Initiierung einer neuen Therapie ausgeprägt sein dürfte (10, 38).”
BackgroundPatterns of Warning Signs Among Adolescents Who Contemplate Suicide: A Latent Profile Analysis
Bertuccio, R. F., Frank, J. L., & Hall, C. M. (2021) · School Psychology Review · doi:10.1080/2372966x.2020.1836519 · Cited by 13
“Research shows that individuals often contemplate or plan suicide prior to attempting suicide (Brent et al., 2009; Lewinsohn et al., 1996; Prinstein et al., 2008).”
BackgroundPlener, P. L., Fegert, J. M., & Kölch, M. G. (2012) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000196 · Cited by 12
In‐Albon, T., Becker, K., Brunner, R. M., Brown, R. C., Kaess, M., Kapusta, N. D., Klein‐Heßling, J., Merod, R., & Plener, P. L. (2017) · Zeitschrift für Klinische Psychologie und Psychotherapie · doi:10.1026/1616-3443/a000398 · Cited by 10
Wood, E. K., Kruger, R., Day, J. P., Day, S. M., Hunter, J. N., Neville, L., Lindell, S. G., Barr, C. S., Schwandt, M. L., Goldman, D. A., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-00994-8 · Cited by 10
“Nevertheless, many do not respond to benzodiazepines, and in some individuals with NSSI, rates of self-injury may even increase following benzodiazepine administration [34].”
BackgroundInfluentialZainal, N. H. (2023) · Psychological Medicine · doi:10.1017/s0033291723003306 · Cited by 10
Simultaneous Benzodiazepine and SSRI Initiation in Young People With Anxiety Disorders
Bushnell, G., Rynn, M. A., Crystal, S., Gerhard, T., & Olfson, M. (2021) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.20m13863 · Cited by 10
Trace elements and physical activity in children and adolescents with depression
Donma, M. M., & Donma, O. (2010) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-0811-33 · Cited by 14
Pharmacotherapy and psychotherapy of pediatric depression
Maalouf, F. T., & Brent, D. A. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.496451 · Cited by 11
“More suicidal adverse events occurred when medication was the only provided treatment compared with a combination of medication and therapy in one study [46] but not in other depression treatment trials [44].”
BackgroundResultInfluentialSelf-citationTrajectories of parent criticism across treatment for youth self‐harm
Aitken, M., Perquier, F., Park, B., Carvalho, D., Wright-Hughes, A. M., Cottrell, D. J., & Szatmári, P. (2025) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.14144 · Cited by 8
Lee, E. A. D. (2011) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.2011.00312.x · Cited by 8
Comparative Analysis of Self-Injury in People with Psychopathology or Neurodevelopmental Disorders
Crapper, L., & Ernst, C. (2015) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2015.03.001 · Cited by 9
Kennedy-Turner, J., Nemeth, Z., & Anderson, L. (2025) · Adolescent Research Review · doi:10.1007/s40894-025-00261-7 · Cited by 7
Nonsuicidal Self-Injury Among Youth
Miller, A. B., Massing‐Schaffer, M., Owens, S., & Prinstein, M. J. (2018) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190634841.013.34 · Cited by 7
Rodríguez-Quiroga, A., Flamarique, I., Castro‐Fornieles, J., Lievesley, K., Buitelaar, J. K., Coghill, D., Díaz‐Caneja, C. M., Dittmann, R., Gupta, A. K., Hoekstra, P. J., et al. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-019-01328-2 · Cited by 8
Treatment-resistant depression in children and adolescents
Chang, J.-C., Hai-Ti-Lin, Wang, Y.-C., & Gau, S. S. (2023) · Progress in brain research · doi:10.1016/bs.pbr.2023.03.004 · Cited by 7
Ghaziuddin, N., Merchant, C. R., Dopp, R. R., & King, C. A. (2014) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2014.03.014 · Cited by 7
Discontinuation of Quetiapine From an NIMH-Funded Trial Due to Serious Adverse Events
Jeste, D. V., Jin, H., Golshan, S., Mudaliar, S. R. D., Glorioso, D., Fellows, I. E., KRAEMER, H. C., & Arndt, S. V. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040501 · Cited by 7
Thriemer, K., Commons, R. J., Rajasekhar, M., Degaga, T. S., Chand, K., Châu, N. H., Assefa, A., Naddim, M. N., Pasaribu, A. P., Awab, G. R., et al. (2023) · BMC Medical Research Methodology · doi:10.1186/s12874-023-02022-3 · Cited by 6
“The wording of inter-view questions and the attitude of the interviewer can also influence the trial participants’ responses [3–5].”
BackgroundBushnell, G., Rynn, M. A., Gerhard, T., Keyes, K. M., Hasin, D. S., Cerdá, M., Nyandege, A. N., & Olfson, M. (2023) · Addiction · doi:10.1111/add.16359 · Cited by 6
Antidepressants at Autopsy in Hispanic Suicidal Youth in Miami-Dade County, Florida*
Cortes, E., Cubano, A., Lewis, J. E., & Castellanos, D. (2010) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2010.01541.x · Cited by 6
Case 16-2013: A 12-Year-Old Girl with Irritability, Hypersomnia, and Somatic Symptoms
Bender, S. L., Sherry, N., & Masia, R. (2013) · New England Journal of Medicine · doi:10.1056/nejmcpc1208145 · Cited by 7
Optimizing family intervention in the treatment of suicidal youth
Diamond, G. S., Asarnow, J. R., & Hughes, J. L. (2014) · Cited by 9
Self-citationAntidepressants in paediatric depression: do not look back in anger but around in awareness
Brent, D. A., Gibbons, R. D., Wilkinson, P. O., & Dubicka, B. (2018) · BJPsych Bulletin · doi:10.1192/bjb.2017.2 · Cited by 8
“11,26 Moreover, these meta-analyses are consistent with the view that other anti-depressants, such as sertraline and escitalopram, are reasonable and e ff ective alternatives should patients have a history of not responding to an adequate trial of fl uoxetine.”
Self-citationCole, J. C. M., Walter, H. J., & DeMaso, D. R. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0755-7.00025-7 · Cited by 7
Annual Research Review: Self‐harm in young people
Ougrin, D., & Kaess, M. (2026) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.70112 · Cited by 5
Should antidepressants be used to treat childhood depression?
Du, Y. (2013) · PubMed Central · doi:10.3969/j.issn.1002-0829.2013.01.001 · Cited by 5
“[10] Though not formally approved for use in depression, fluvoxamine (for children over 8 years old) and sertraline (for children over 6 years old) have been approved by the FDA for treating children with obsessive-compulsive disorder and several doubleblind randomized controlled trials (RCTs) have shown that both of…”
BackgroundPediatric hospital screening for suicide risk in adolescents referred for maltreatment
Azzopardi, C., Greenblatt, A., Korczak, D. J., & Smith, T. D. (2020) · Children and Youth Services Review · doi:10.1016/j.childyouth.2020.105500 · Cited by 5
Conner, K. R., Syd, P., Beautrais, A. L., Brent, D. A., Conwell, Y., Phillips, R., & Schneider, B. (2011) · Cited by 5
Self-citationPiatkov, I., Jones, T., & Vuuren, R. J. V. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00566.x · Cited by 4
Aitken, M., Sagar, A., Courtney, D., & Szatmári, P. (2023) · JCPP Advances · doi:10.1002/jcv2.12168 · Cited by 5
Pharmacological Treatment of Non-suicidal Self-injury and Eating Disorders
Plener, P. L., & Schulze, U. (2013) · Springer eBooks · doi:10.1007/978-3-642-40107-7_12 · Cited by 4
Shoval, G., Nahshoni, E., Gothelf, D., Manor, I., Golobchik, P., Zemishlany, Z., Weizman, A., & Zalsman, G. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31822cb863 · Cited by 4
“One possibility is that this may be a result of adverse effects of the medication itself, as was shown in recent studies, suggesting that SSRIs may increase suicidal behavior in adolescents.(18,19) This concern resulted in the 2003 Food and Drug Administration black box warning for this drug group.”
ResultCarpenter, W. T. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030385 · Cited by 4
Dardas, L. A. (2017) · DukeSpace (Duke University) · Cited by 8
The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder
Castagna, P. J., Farahdel, E., Potenza, M. N., & Crowley, M. J. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2199921 · Cited by 3
“Further, there are some concerns with SNRI tolerability and evidence of increased treatment-emergent suicidality in pediatric depression [70,71].”
BackgroundEggart, V., Mortazavi, M., Kirchner, S.-K., Keeser, D., Brandstetter, L., Hasan, A., & Wagner, E. M. (2023) · Pharmacopsychiatry · doi:10.1055/a-2153-4370 · Cited by 3
Self-harming behavior in adolescents: Current diagnostic and therapeutic approaches
Yazıcı, M., & Hocaoğlu, Ç. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002918 · Cited by 3
Koslow, S. H., Ruiz, P., & Nemeroff, C. B. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139519502.019 · Cited by 3
Health Economics: The Hidden Costs of Mental Illness
Martini, D. R., & Attallah, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-12665-0_1 · Cited by 3
Assessing Psychiatric Adverse Effects during Clinical Drug Development
Rudorfer, M. V., & Hillefors, M. (2012) · Pharmaceutical Medicine · doi:10.1007/bf03262382 · Cited by 3
Andover, M. S., Wren, A., Schatten, H. T., Morris, B. W., Shashoua, M. Y., & Holman, C. S. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7497-6_33 · Cited by 3
Bronisch, T. (2018) · NeuroTransmitter · doi:10.1007/s15016-018-6214-2 · Cited by 3
Pediatric anxiety: An update for primary care NPs
Foreman, R. M., & Zappas, M. P. (2023) · The Nurse Practitioner · doi:10.1097/01.npr.0000000000000015 · Cited by 2
“Benzodiazepines, which also do not have an FDA indication for the treatment of pediatric anxiety, remain controversial: a recent study found an association between benzodiazepines and suicidality, with suicidal adverse events—defi ned as new or worsening suicidal ideation, a suicidal threat, or a suicide attempt withi…”
BackgroundA Narrative Review: Serotonin Reuptake Inhibitors and the Risk of Suicidal Ideation in Adolescents
Gage, D. S., Priefer, V. E., & Priefer, R. (2025) · Adolescents · doi:10.3390/adolescents5010005 · Cited by 2
“Obtaining similar results, the Treatment of SSRI Resistant Depression in Adolescents (TORDIA) trial was conducted between 2000 and 2006, at six US academic and community clinics [14,33–36].”
Brent, D. A. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.011 · Cited by 2
Self-citationSuicide in teens and young adults in the United States
Baron, D. A., Paglia, C., Thorkelson, G., & Namdari, M. (2009) · Quaderni Italiani di Psichiatria · doi:10.1016/j.quip.2009.04.004 · Cited by 2
Treatment-Resistant Depression in Adolescents: A Comprehensive Review
Carandang, C. G. (2013) · Journal of Depression & Anxiety · doi:10.4172/2167-1044.1000128 · Cited by 2
A Need for Personalised Suicidology: Pharmacoepidemiology
Tournier, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-26282-6_32 · Cited by 2
Interpersonal Factors and Suicidal Ideation in Asian American College Freshmen.
Chang, R. (2010) · Deep Blue (University of Michigan) · Cited by 2
New Studies on Suicide and Self-Harm
Hocaoğlu, Ç. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1000386 · Cited by 3
NON-SUICIDAL SELF-HARM: TRANSLATING FINDINGS INTO STRATEGIES
Masters, K. J. (2015) · JAACAP Connect · doi:10.62414/001c.92637 · Cited by 1
Rogalski, J. K., & Tomczak, T. (2024) · Health Problems of Civilization · doi:10.5114/hpc.2024.136000 · Cited by 1
Managing the risk of suicide in people with treatment-resistant depression
Franz, P. J., & Alpert, J. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00039-6 · Cited by 1
Novel (Atypical) Antidepressants
Bruty, H. R., Emslie, G. J., & Croarkin, P. E. (2012) · Wiley eBooks · doi:10.1002/9781119958338.ch9 · Cited by 1
Self-citationAntidepressants and suicidal ideation in adolescence: A paradoxical effect
Pierson, E. E. (2009) · Psychology in the Schools · doi:10.1002/pits.20432 · Cited by 1
Morris, D. W. (2012) · Clinical Investigation · doi:10.4155/cli.12.142 · Cited by 1
Emslie, G. J. (2013) · Bipolar Disorders · doi:10.1111/bdi.12043 · Cited by 1
Self-citationMitchell, P. B. (2011) · Side effects of drugs annual · doi:10.1016/b978-0-444-53741-6.00002-7 · Cited by 1
Understanding Why: Drivers of Suicide Risk
Moutier, C. Y., Pisani, A. R., & Stahl, S. M. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108564618.004 · Cited by 1
The problem of suicide in depression in the modern world
Петрова, Н. Н. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212206243 · Cited by 2
Selective serotonin re-uptake inhibitors (SSRIs)
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01440-2 · Cited by 1
Pharmacological Treatment of Suicidality in Affective and Psychotic Disorders
Bronisch, T. (2022) · Springer eBooks · doi:10.1007/978-3-030-42003-1_69 · Cited by 1
Stahl, S. M., & Strawn, J. R. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009267526.055 · Cited by 1
Parental involvement and depressive symptoms among adolescentsPreprint
Pavlenko, K., Бочавер, А. А., Сивак, Е., & Smirnov, I. (2021) · SocArXiv (OSF Preprints) · doi:10.31235/osf.io/3wa8g · Cited by 1
Goldstein, T. R., Bridge, J. A., & Brent, D. A. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139519502.020 · Cited by 1
Self-citationRossouw, T. I. (2013) · UCL Discovery (University College London) · Cited by 5
McGrath, P. J., & Roose, S. P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.004
Potential Limitations in Generalizing Findings From the TORDIA Study
Moore, S. M., & Cooney, J. G. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09050639
TORDIA: Unique Opportunity to Explore Half-Life Theory
Smith, E. G. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09050601
Evidence-Based Treatment of Unipolar Depression in Adolescents
Loyola, G. (2010) · UA Campus Repository (The University of Arizona) · Cited by 1
Ali, L. (2013) · HEC National Digital Library
Metadata
- Authors
- Brent, D. A., Emslie, G. J., Clarke, G. N., Asarnow, J., Spirito, A., Ritz, L., Vitiello, B., Iyengar, S., Birmaher, B., Ryan, N. D., Zelazny, J., Onorato, M., Kennard, B., Mayes, T. L., DeBar, L. L., McCracken, J. T., Strober, M., Suddath, R., Leonard, H., Porta, G., & Keller, M. B.
- Affiliations
- University of Pittsburgh (US)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2009-04
- Volume
- 166
- Issue
- 4
- Pages
- 418-426
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC3593721
- OpenAlex
- W2124714257
- Cited by
- 235
- References
- 34
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 4 · 2023: 17 · 2022: 7 · 2021: 14 · 2020: 19 · 2019: 12 · 2018: 10 · 2017: 10 · 2016: 13 · 2015: 10 · 2014: 14 · 2013: 17 · 2012: 25
- FWCI
- 27.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- National Institute of Mental Health (U01MH061835, U01MH062014)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- non-suicidal self-injury, treatment-resistant depression, adolescent depression, SSRI antidepressants, venlafaxine, cognitive behavioral therapy, suicidal ideation, family conflict, benzodiazepines, adverse event monitoring
- MeSH terms
- Venlafaxine Hydrochloride, Adolescent, Antidepressive Agents, Benzodiazepines, Cross-Sectional Studies, Cyclohexanols, Major Depressive Disorder, Depressive Disorder, Major, Drug Interactions, Drug Resistance, Drug Therapy, Combination, Female, Fluoxetine, Humans, Male, Suicide, Suicide, Attempted, Citalopram, Cognitive Behavioral Therapy, Self-Injurious Behavior, Selective Serotonin Reuptake Inhibitors, Paroxetine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.